- Home
- CLGN vs KPLT Comparison
CLGN vs KPLT Comparison
Compare CLGN & KPLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLGN
- KPLT
- Stock Information
- Founded
- CLGN 2004
- KPLT 2012
- Country
- CLGN Israel
- KPLT United States
- Employees
- CLGN N/A
- KPLT N/A
- Industry
- CLGN Industrial Specialties
- KPLT Diversified Commercial Services
- Sector
- CLGN Health Care
- KPLT Consumer Discretionary
- Exchange
- CLGN Nasdaq
- KPLT Nasdaq
- Market Cap
- CLGN 22.1M
- KPLT 35.6M
- IPO Year
- CLGN N/A
- KPLT N/A
- Fundamental
- Price
- CLGN $3.18
- KPLT $9.00
- Analyst Decision
- CLGN Strong Buy
- KPLT Hold
- Analyst Count
- CLGN 2
- KPLT 2
- Target Price
- CLGN $11.50
- KPLT $12.00
- AVG Volume (30 Days)
- CLGN 165.3K
- KPLT 53.1K
- Earning Date
- CLGN 05-28-2025
- KPLT 05-15-2025
- Dividend Yield
- CLGN N/A
- KPLT N/A
- EPS Growth
- CLGN N/A
- KPLT N/A
- EPS
- CLGN N/A
- KPLT N/A
- Revenue
- CLGN $2,472,000.00
- KPLT $254,079,000.00
- Revenue This Year
- CLGN $2,177.67
- KPLT $20.12
- Revenue Next Year
- CLGN $56.52
- KPLT $13.19
- P/E Ratio
- CLGN N/A
- KPLT N/A
- Revenue Growth
- CLGN N/A
- KPLT 9.72
- 52 Week Low
- CLGN $1.55
- KPLT $5.08
- 52 Week High
- CLGN $5.63
- KPLT $21.88
- Technical
- Relative Strength Index (RSI)
- CLGN 59.91
- KPLT 60.14
- Support Level
- CLGN $1.90
- KPLT $8.22
- Resistance Level
- CLGN $4.98
- KPLT $9.11
- Average True Range (ATR)
- CLGN 0.40
- KPLT 0.77
- MACD
- CLGN 0.25
- KPLT 0.19
- Stochastic Oscillator
- CLGN 47.52
- KPLT 84.93
About CLGN CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
About KPLT Katapult Holdings Inc.
Katapult Holdings Inc. is a technology-driven lease-to-own platform that integrates with omni-channel retailers and e-commerce platforms to power the purchase of everyday durable goods for underserved U.S. non-prime consumers. It is an e-commerce-focused FinTech company offering a lease-purchase solution to consumers and enabling essential transactions at the merchant point of sale. Katapult is associated with hundreds of retailers across the United States.